Rigel Pharmaceuticals, Inc.
RIGLBiotechnology
$51.45+1.40%As of Oct 29vs prior close
- Market cap
- $951.9M
- P/E (TTM)
- 2.9×
- P/E (FY1)
- 14.5×
- From 52W high
- 0.00%
- EPS (LTM)
- $16.89
- Revenue (LTM)
- $276.8M
- Net margin
- 116.30%
- Dividend yield
- 0.00%
Nomior Score
75
Discounted QualitySpeculativeTop 5% of the scored universe
Growth60
Quality75
Value70
Momentum68
Resilience53
Growth
+34.53%revenue a year over 9 fiscal years
YE16 $20.4MLTM $276.8M
Connections
Revenue to profitQ2 YE26
22% of revenue became net profit, down 37 pts on a year.
Who owns it
2funds